kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
JP Stock MarketDetailed Quotes
4958 T Hasegawa
- 2781
- +2+0.07%
20min DelayNot Open Feb 18 15:30 JST
118.77BMarket Cap15.96P/E (Static)
2784High2741Low47.80KVolume2756Open2779Pre Close132.25MTurnover352552wk High0.16%Turnover Ratio42.71MShares252152wk Low177.54EPS TTM82.29BFloat Cap3630Historical High15.96P/E (Static)29.59MShs Float798Historical Low174.27EPS LYR1.55%Amplitude70.00Dividend TTM0.92P/B100Lot Size2.52%Div YieldTTM
T Hasegawa Key Stats
Quarterly+Annual
YOY
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.49%17.64B | 10.44%71.65B | 7.86%17.04B | 5.79%16.41B | 3.97%64.87B | 16.71B | 1.57%16.85B | 6.00%15.8B | 8.53%15.52B | 11.91%62.4B |
| Cost of revenue | 5.19%10.23B | 7.19%42B | 4.48%9.9B | 3.27%9.72B | 6.55%39.19B | 10.34B | 2.70%9.96B | 9.43%9.47B | 11.34%9.41B | 11.09%36.78B |
| Gross profit | 10.84%7.42B | 15.39%29.64B | 12.90%7.14B | 9.69%6.69B | 0.26%25.69B | 6.37B | -0.01%6.89B | 1.26%6.33B | 4.47%6.1B | 13.13%25.62B |
| Operating expense | 13.41%5.51B | 11.50%20.27B | 9.45%4.68B | 6.44%4.86B | 3.48%18.18B | 4.8B | 1.07%4.53B | 5.77%4.27B | 8.14%4.57B | 11.28%17.57B |
| Staff costs | ---- | 10.10%11.71B | ---- | ---- | 3.37%10.63B | ---- | ---- | ---- | ---- | 9.45%10.29B |
| Selling and administrative expenses | ---- | 9.60%1.36B | ---- | ---- | -1.67%1.24B | ---- | ---- | ---- | ---- | 18.85%1.26B |
| -General and administrative expense | ---- | 9.60%1.36B | ---- | ---- | -1.67%1.24B | ---- | ---- | ---- | ---- | 18.85%1.26B |
| Depreciation and amortization | ---- | 8.15%2.69B | ---- | ---- | 10.81%2.49B | ---- | ---- | ---- | ---- | 28.84%2.25B |
| -Depreciation | ---- | 8.43%1.71B | ---- | ---- | 10.89%1.58B | ---- | ---- | ---- | ---- | 21.42%1.42B |
| -Amortization | ---- | 7.68%982M | ---- | ---- | 10.68%912M | ---- | ---- | ---- | ---- | 44.06%824M |
| Other operating expenses | ---- | 18.22%4.51B | ---- | ---- | 1.14%3.81B | ---- | ---- | ---- | ---- | 5.31%3.77B |
| Operating profit | 3.99%1.9B | 24.80%9.37B | 20.06%2.47B | 19.39%1.83B | -6.77%7.51B | 1.57B | -2.03%2.36B | -6.97%2.05B | -5.14%1.53B | 17.38%8.06B |
| Net non-operating interest income (expenses) | 32.79%81M | 30.96%258M | 26.32%48M | 45.24%61M | 26.28%197M | 68M | 16.67%49M | 8.57%38M | 13.51%42M | 43.12%156M |
| Non-operating interest income | 28.36%86M | 38.24%282M | 35.00%54M | 55.81%67M | 25.15%204M | --70M | 15.91%51M | 8.11%40M | 13.16%43M | 39.32%163M |
| Non-operating interest expense | -16.67%5M | 242.86%24M | 200.00%6M | 500.00%6M | 0.00%7M | --2M | 0.00%2M | 0.00%2M | 0.00%1M | -12.50%7M |
| Net investment income | 522.39%283M | -75.99%85M | 23.13%181M | 58.90%-67M | -54.26%354M | 150M | -10.57%220M | -35.81%147M | -285.23%-163M | 83.85%774M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -33.50%800M | -46.05%1.2B | 0 | -45.53%950M | -1.55%2.23B | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -150.00%-5M | -506.15%-394M | 12.50%-21M | 80.00%-2M | -71.05%-65M | -23M | -300.00%-8M | -166.67%-24M | -150.00%-10M | 0.00%-38M |
| Less:Other special charges | 150.00%5M | 441.54%352M | -12.50%21M | -80.00%2M | 71.05%65M | --23M | 300.00%8M | 166.67%24M | 150.00%10M | 0.00%38M |
| Less:Write off | ---- | --42M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -31.25%22M | -58.40%52M | -94.44%3M | 28.00%32M | 32.98%125M | 6M | 11.11%40M | 54.29%54M | 38.89%25M | 22.08%94M |
| Income before tax | 23.22%2.28B | 9.10%10.17B | 6.26%2.68B | 29.96%1.85B | -17.26%9.32B | 1.77B | -19.31%3.61B | -15.51%2.52B | -18.76%1.43B | 16.25%11.27B |
| Income tax | 57.69%820M | 12.00%2.97B | 10.01%813M | 35.77%520M | -17.37%2.65B | 448M | -12.62%1.08B | -14.47%739M | -26.49%383M | 9.49%3.21B |
| Net income | 9.77%1.46B | 7.94%7.2B | 4.71%1.87B | 27.86%1.33B | -17.23%6.67B | 1.32B | -21.81%2.53B | -15.98%1.78B | -15.50%1.04B | 19.18%8.06B |
| Net income continuous operations | 9.76%1.46B | 7.94%7.2B | 4.71%1.87B | 27.83%1.33B | -17.22%6.67B | --1.32B | -21.87%2.53B | -15.94%1.78B | -15.49%1.04B | 19.18%8.06B |
| Noncontrolling interests | 53M | |||||||||
| Net income attributable to the company | 9.77%1.46B | 7.94%7.2B | 4.71%1.87B | 27.86%1.33B | -16.69%6.67B | 1.32B | -21.40%2.53B | -15.14%1.78B | -14.46%1.04B | 18.39%8.01B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 9.77%1.46B | 7.94%7.2B | 4.71%1.87B | 27.86%1.33B | -16.69%6.67B | 1.32B | -21.40%2.53B | -15.14%1.78B | -14.46%1.04B | 18.39%8.01B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 10.20%35.65 | 7.94%175.04 | 4.71%45.39 | 27.87%32.35 | -16.69%162.16 | 32 | -21.41%61.51 | -15.15%43.35 | -14.53%25.3 | 18.96%194.65 |
| Diluted earnings per share | 10.15%35.49 | 7.88%174.27 | 4.70%45.21 | 27.76%32.22 | -16.72%161.54 | 31.86 | -21.48%61.28 | -15.23%43.18 | -14.51%25.22 | 19.00%193.97 |
| Dividend per share | 0 | 14.75%70 | 3.33%31 | 0 | 0.00%61 | 31 | 0 | 3.45%30 | 0 | 38.64%61 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |